This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Panic Attacks Associated With Topiramate

Cristian Damsa, MD; Stella Warczyk, MD; Lionel Cailhol, MD; A. Melisande Kelley-Puskas, MD; Andrei Cicotti, MD; Coralie Lazignac, MD; Antonio Andreoli, MD

Published: February 15, 2006

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Although topiramate is not registered in Switzerland for the treatment of bipolar disorder, it is widely prescribed for this disorder, especially in patients suffering from comorbid conditions such as weight gain.1 We report a patient who experienced panic attacks associated with topiramate treatment. Case report. Ms. A, a 27-year-old woman with bipolar II disorder (according to the Structured Clinical Interview for DSM-IV Axis I Disorders2), had, in 2004, been stabilized for 3 months with lithium, 1200 mg/day.’ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 67

Quick Links: Anxiety , Panic Disorder

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...